- published: 22 Apr 2016
- views: 1189
On 25 April 2016, CSL marks its 100th anniversary. A century ago, CSL made a promise to protect the health of a nation and help save and improve the lives of people with serious diseases. Today, this same promise is stronger than ever. Over the last 100 years, CSL has grown into a global biotherapeutics leader delivering innovative therapies to patients all around the world. With a unique combination of R&D; focus, operational excellence and commercial strength, CSL is well-positioned to continue its leadership into the second century. In fact in many ways, we are just getting started.
CSL Behring is one of the world’s leading companies in the bioplasma therapeutics industry. Every year CSL Behring processes approx. 10 million litres of human blood plasma to manufacture its therapeutics. The medication the company manufactures in Switzerland is particularly sensitive to changes in temperature. It needs to be refrigerated as soon as production is complete. If transportation over longer distances is required, it needs to be wrapped in a special cold chain packaging with cooling elements, making sure the temperature remains between 2 and 8 °Celsius. For this task, they have chosen FedEx. http://www.cslbehring.ch; http://www.fedex.com/uk
Produktionsfachkräfte haben alles im Blick und arbeiten im Herzen von CSL Behring: in der Herstellung der Medikamente. Hat Dir Janas Film gefallen? Dann bewirb Dich doch als Produktionsfachkraft Chemie unter http://marburg.cslbehring.de Rechtliche Hinweise: Die hier in den Videos zur Verfügung gestellten Inhalte wurden sorgfältig erarbeitet und erfüllen einen hohen Qualitätsanspruch. Medizinische Texte wurden von Fachexperten erstellt und in regelmäßigen Abständen auf ihre Richtigkeit überprüft und aktualisiert. Die medizinischen Erkenntnisse unterliegen einem steten Wandel, so dass trotz größter Sorgfalt keine Gewähr für die Vollständigkeit, Richtigkeit, Genauigkeit und Aktualität der Inhalte in den Videos übernommen wird. Das Informationsangebot dient ausschließlich Ihrer Information u...
CSL CEO Paul Perreault is interviewed on the FOX Business News "Opening Bell" program. Mr. Perreault talks about CSL's R&D; spend, the hemophilia space and the company's strategies for growth. Learn more about CSL Behring at http://www.CSLBehring.com ©2014 CSL Behring LLC 1020 First Avenue, PO Box 61501, King of Prussia, PA 19406-0901 USA http://www.CSLBehring.com
Mix2Vial® – Needleless Transfer Device CSL Behring Biotherapies for Life® Welcome to the self-administration training video for the Mix2Vial. The Mix2Vial is a needle-free transfer device that offers you an efficient and convenient way to reconstitute lyophilized products. The needle-free design minimizes the risk of accidental injury and the time to prepare factor concentrates produced by CSL Behring for infusion. CSL Behring Canada created this educational video to help patients and healthcare providers learn the proper techniques for the safe and simple way to reconstitute lyophilized biotherapy concentrates using the Mix2Vial in a home care or clinical setting. This presentation should be used in conjunction with training provided by your health care professional. The content within...
CSL Behring in Bradley, near Kankakee, Illinois
Swissbau Focus 2016, Freitag, 15. Januar 2016, 11.15 - 12.45 Uhr Induzierte Mobilität: Wie beeinflussen Bautätigkeit und Planung das Verkehrswachstum? Veranstalter: EnergieSchweiz, Energiestadt Weitere Informationen zum Event finden sie hier: http://www.swissbau.ch/de-CH/news/blog/2016/01/15-induzierte-mobilitaet.aspx